Phase 3
N=2,700
Randomized Controlled Trial of Routine Screening for IPV
Quality of Life · Disability · Utilization of Health Care Services
Bottom Line
View on ClinicalTrials.gov: NCT00526994 ↗Enrolled (actual)
2,700
Serious AEs
0.0%
Results posted
Jul 2013
Primary outcome: Primary: Quality of Life, Physical Health Composite — 46.8; 46.4; 47.2 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 3
- Interventions
- screened (Other); universal education (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- Centers for Disease Control and Prevention
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quality of Life, Physical Health Composite |
46.8; 46.4; 47.2 | — |
| PRIMARY Quality of Life, Mental Health Composite |
48.3; 48.0; 47.8 | — |
| SECONDARY Utilization of Health Care |
5.4; 5.7; 5.9 | — |
| SECONDARY Disability |
1.9; 2.2; 1.9 | — |
Summary
This is a randomized controlled trial with three arms to establish the impact of screening and referral to services for women disclosing exposure to IPV.
Eligibility Criteria
Inclusion Criteria
- women attending obstetrics & gynecology (OB-GYN), family planning, general medicine, family medicine or HIV/Sexually transmitted disease (STD) clinic
Exclusion Criteria
- non-English speaking other than Spanish speakers
- accompanied by a child >3 years of age without adequate provision for child care;
- Visually- or hearing-impaired women;
- without access to a telephone;
- Severe Mental impairment
Data sourced from ClinicalTrials.gov (NCT00526994). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.